Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 319
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies 2024 Marinato, Gian MarcoPasello, GiuliaGuarneri, ValentinaBonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports 2024 Boscolo Bragadin, AndreaGuarneri, ValentinaBonanno, LauraIndraccolo, Stefano + FRONTIERS IN ONCOLOGY - -
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis 2024 Bonanno, LauraDal Maso, AlessandroPavan, AlbertoPasello, GiuliaGuarneri, Valentina + FRONTIERS IN IMMUNOLOGY - -
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 2024 Pasello, GiuliaSalizzato, ValentinaPiccin, LuisaBonanno, LauraGuarneri, Valentina + JOURNAL OF TRANSLATIONAL MEDICINE - -
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 2024 Bonanno, LauraZingone, FabianaBarberio, BrigidaDal Maso, AlessandroPasello, GiuliaDei Tos, Angelo PaoloFassan, MatteoSavarino, Edoardo VincenzoGuarneri, Valentina + THE ONCOLOGIST - -
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients 2024 Bonanno, LauraDal Maso, AlessandroGuarneri, ValentinaPasello, Giulia + FRONTIERS IN IMMUNOLOGY - -
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 2024 Dieci, Maria VittoriaGriguolo, GaiaMiglietta, FedericaGuarneri, Valentina + JOURNAL OF THE NATIONAL CANCER INSTITUTE - -
Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs) 2024 Guarneri, Valentina + CANCER TREATMENT REVIEWS - -
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer 2024 Guarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion–positive non–small cell lung cancer: a case report 2023 Guarneri V.Pasello G. + FRONTIERS IN ONCOLOGY - -
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy 2023 Guarneri, Valentina + JOURNAL OF CLINICAL ONCOLOGY - -
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer 2023 Guarneri, Valentina + JOURNAL OF CLINICAL ONCOLOGY - -
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA) 2023 Guarneri, V + ESMO OPEN - -
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 2023 Guarneri, V. + ANNALS OF ONCOLOGY - -
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial 2023 Guarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 2023 Miglietta, FDieci, M VConte, P FGuarneri, V + CANCER TREATMENT REVIEWS - -
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial 2023 Dieci, Maria VittoriaConte, PierfrancoGuarneri, Valentina + NPJ BREAST CANCER - -
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study 2023 Cerretti, GPadovan, MCaccese, MDenaro, LGuarneri, VLombardi, G + CLINICAL ONCOLOGY - -
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - -
Fertility Counseling Pattern over Time in Young Patients with Breast Cancer: A Retrospective Analysis at a Large Comprehensive Cancer Center 2023 Barbieri, CMarin, LAndrisani, ASaccardi, CDi Liso, ETozzi, RGuarneri, VDieci, MV + CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY - -
Mostrati risultati da 1 a 20 di 319
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile